Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

454.00
-4.0500-0.88%
Post-market: 457.833.83+0.84%19:57 EDT
Volume:2.20M
Turnover:1.00B
Market Cap:115.19B
PE:29.63
High:461.05
Open:454.62
Low:452.89
Close:458.05
52wk High:513.98
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.61
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.17
PE(LYR):29.63

Loading ...

Vertex Pharmaceuticals EVP, CO & FO Charles F. Wagner Jr. Reports Disposal of Common Shares

Reuters
·
Jan 09

Vertex Pharmaceuticals (VRTX) Is Up 6.8% After IgA Nephropathy Outlook Upgrade - Has The Bull Case Changed?

Simply Wall St.
·
Jan 09

Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $625 From $604, Maintains Buy Rating

MT Newswires Live
·
Jan 09

Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story

TIPRANKS
·
Jan 09

Vertex Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jan 08

UBS Adjusts Price Target on Vertex Pharmaceuticals to $535 From $546, Maintains Buy Rating

MT Newswires Live
·
Jan 07

Vertex Pharmaceuticals Coverage Assumed by UBS at Buy

Dow Jones
·
Jan 07

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 07

Vertex Pharmaceuticals Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla

Reuters
·
Jan 07

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

Reuters
·
Jan 06

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Reuters
·
Jan 06

Built In Honors Vertex in Its Esteemed 2026 Best Places To Work Awards

GlobeNewswire
·
Jan 06

Vertex Pharmaceuticals Raised to Outperform From Peer Perform by Wolfe Research

Dow Jones
·
Jan 06

BUZZ-Citi sees momentum in US pharma and biotech into 2026, updates ratings on top picks

Reuters
·
Jan 06

Wolfe Research Upgrades Vertex Pharmaceuticals to Outperform From Peer Perform, Price Target is $548

MT Newswires Live
·
Jan 06

When Phase 3 Data Drops, What Determines A Sustained Rally Vs. A Fading Initial Pop

Benzinga_recent_news
·
Jan 01